Oleanolic Acid Provides Neuroprotection Against Ischemic Stroke Through the Inhibition of Microglial Activation and NLRP3 Inflammasome Activation

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2021 Dec 7

PMID 34873072

Citations 12

Authors

Arjun Sapkota

Ji Woong Choi

Affiliations

Soon will be listed here.

Abstract

Oleanolic acid (OA), a natural pentacyclic triterpenoid, has been reported to exert protective effects against several neurological diseases through its anti-oxidative and anti-inflammatory activities. The goal of the present study was to evaluate the therapeutic potential of OA against acute and chronic brain injuries after ischemic stroke using a mouse model of transient middle cerebral artery occlusion (tMCAO, MCAO/reperfusion). OA administration immediately after reperfusion significantly attenuated acute brain injuries including brain infarction, functional neurological deficits, and neuronal apoptosis. Moreover, delayed administration of OA (at 3 h after reperfusion) attenuated brain infarction and improved functional neurological deficits during the acute phase. Such neuroprotective effects were associated with attenuation of microglial activation and lipid peroxidation in the injured brain after the tMCAO challenge. OA also attenuated NLRP3 inflammasome activation in activated microglia during the acute phase. In addition, daily administration of OA for 7 days starting from either immediately after reperfusion or 1 day after reperfusion significantly improved functional neurological deficits and attenuated brain tissue loss up to 21 days after the tMCAO challenge; these findings supported therapeutic effects of OA against ischemic stroke-induced chronic brain injury. Together, these findings showed that OA exerted neuroprotective effects against both acute and chronic brain injuries after tMCAO challenge, suggesting that OA is a potential therapeutic agent to treat ischemic stroke.

Citing Articles

Improving anti-oxidant stress treatment of subarachnoid hemorrhage through self-assembled nanoparticles of oleanolic acid.

Zhou Y, Wang H, Zhu X, Zhao Q, Deng G, Li Y Drug Deliv. 2024; 31(1):2388735.

PMID: 39169653 PMC: 11342817. DOI: 10.1080/10717544.2024.2388735.

Principal Bioactive Properties of Oleanolic Acid, Its Derivatives, and Analogues.

Jannus F, Sainz J, Reyes-Zurita F Molecules. 2024; 29(14).

PMID: 39064870 PMC: 11279785. DOI: 10.3390/molecules29143291.

Biological Activities of Novel Oleanolic Acid Derivatives from Bioconversion and Semi-Synthesis.

Triaa N, Znati M, Ben Jannet H, Bouajila J Molecules. 2024; 29(13).

PMID: 38999041 PMC: 11243203. DOI: 10.3390/molecules29133091.

Oleanolic acid and its analogues: promising therapeutics for kidney disease.

Pan D, Qu Y, Shi C, Xu C, Zhang J, Du H Chin Med. 2024; 19(1):74.

PMID: 38816880 PMC: 11140902. DOI: 10.1186/s13020-024-00934-w.

Lysophosphatidic Acid Receptor 1 Plays a Pathogenic Role in Permanent Brain Ischemic Stroke by Modulating Neuroinflammatory Responses.

Tiwari S, Basnet N, Choi J Biomol Ther (Seoul). 2024; 32(3):319-328.

PMID: 38627097 PMC: 11063482. DOI: 10.4062/biomolther.2024.052.

References

Jayaraj R, Azimullah S, Beiram R, Jalal F, Rosenberg G . Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019; 16(1):142. PMC: 6617684. DOI: 10.1186/s12974-019-1516-2. View

Kim M, Han J, Kim S, Jeon D, Kim H, Lee S . Oleanolic acid acetate attenuates polyhexamethylene guanidine phosphate-induced pulmonary inflammation and fibrosis in mice. Respir Physiol Neurobiol. 2018; 252-253:1-9. DOI: 10.1016/j.resp.2018.03.001. View

Gladstone D, Black S, Hakim A . Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002; 33(8):2123-36. DOI: 10.1161/01.str.0000025518.34157.51. View

Lapchak P . A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?. Expert Opin Pharmacother. 2010; 11(10):1753-63. PMC: 2891515. DOI: 10.1517/14656566.2010.493558. View

Adibhatla R, Hatcher J . Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006; 40(3):376-87. DOI: 10.1016/j.freeradbiomed.2005.08.044. View

Lee C, Sapkota A, Gaire B, Choi J . NLRP3 Inflammasome Activation Is Involved in LPA-Mediated Brain Injury after Transient Focal Cerebral Ischemia. Int J Mol Sci. 2020; 21(22). PMC: 7697439. DOI: 10.3390/ijms21228595. View

Rong Z, Gong X, Sun H, Li Y, Ji H . Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H(2)O(2)-induced injury in vitro. Pharm Biol. 2010; 49(1):78-85. DOI: 10.3109/13880209.2010.499130. View

Msibi Z, Mabandla M . Oleanolic Acid Mitigates 6-Hydroxydopamine Neurotoxicity by Attenuating Intracellular ROS in PC12 Cells and Striatal Microglial Activation in Rat Brains. Front Physiol. 2019; 10:1059. PMC: 6712087. DOI: 10.3389/fphys.2019.01059. View

Abulafia D, de Rivero Vaccari J, Diego Lozano J, Lotocki G, Keane R, Dietrich W . Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J Cereb Blood Flow Metab. 2008; 29(3):534-44. DOI: 10.1038/jcbfm.2008.143. View

10.

Pu H, Shi Y, Zhang L, Lu Z, Ye Q, Leak R . Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke. Proc Natl Acad Sci U S A. 2019; 116(18):9115-9124. PMC: 6500126. DOI: 10.1073/pnas.1821979116. View

11.

Ziberna L, Samec D, Mocan A, Nabavi S, Bishayee A, Farooqi A . Oleanolic Acid Alters Multiple Cell Signaling Pathways: Implication in Cancer Prevention and Therapy. Int J Mol Sci. 2017; 18(3). PMC: 5372655. DOI: 10.3390/ijms18030643. View

12.

Ayeleso T, Matumba M, Mukwevho E . Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases. Molecules. 2017; 22(11). PMC: 6150249. DOI: 10.3390/molecules22111915. View

13.

Jin R, Yang G, Li G . Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol. 2010; 87(5):779-89. PMC: 2858674. DOI: 10.1189/jlb.1109766. View

14.

Castellano J, Guinda A, Delgado T, Rada M, Cayuela J . Biochemical basis of the antidiabetic activity of oleanolic acid and related pentacyclic triterpenes. Diabetes. 2013; 62(6):1791-9. PMC: 3661625. DOI: 10.2337/db12-1215. View

15.

Lenart N, Brough D, Denes A . Inflammasomes link vascular disease with neuroinflammation and brain disorders. J Cereb Blood Flow Metab. 2016; 36(10):1668-1685. PMC: 5076791. DOI: 10.1177/0271678X16662043. View

16.

Xu Q, Zhao B, Ye Y, Li Y, Zhang Y, Xiong X . Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke. J Neuroinflammation. 2021; 18(1):123. PMC: 8166383. DOI: 10.1186/s12974-021-02137-8. View

17.

Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V . ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury. Oxid Med Cell Longev. 2016; 2016:2183026. PMC: 4835650. DOI: 10.1155/2016/2183026. View

18.

Martin R, Hernandez M, Cordova C, Nieto M . Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. Br J Pharmacol. 2012; 166(5):1708-23. PMC: 3419913. DOI: 10.1111/j.1476-5381.2012.01869.x. View

19.

Liu J . Oleanolic acid and ursolic acid: research perspectives. J Ethnopharmacol. 2005; 100(1-2):92-4. DOI: 10.1016/j.jep.2005.05.024. View

20.

OCollins V, Macleod M, Donnan G, Horky L, van der Worp B, Howells D . 1,026 experimental treatments in acute stroke. Ann Neurol. 2006; 59(3):467-77. DOI: 10.1002/ana.20741. View